Role of tumor cell senescence in non-professional phagocytosis and cell-in-cell structure formation

Background Non-professional phagocytosis is usually triggered by stimuli such as necrotic cell death. In tumor therapy, the tumors often disappear slowly and only long time after the end of therapy. Here, tumor therapy inactivates the cells by inducing senescence. Therefore, study focused whether senescence is a stimulus for non-professional phagocytosis or whether senescent cells themselves phagocytize non-professionally. Results Senescence was induced in cell lines by camptothecin and a phagocytosis assay was performed. In tissue of a cohort of 192 rectal cancer patients senescence and non-professional phagocytosis was studied by anti-histone H3K9me3 and anti-E-cadherin staining. Senescent fibroblasts and pancreas carcinoma cells phagocytize necrotic cells but are not phagocytized. In the tissue of rectal carcinoma, senescent cells can phagocytize and can be phagocytized. A high number of senescent cells and, at the same time, high numbers of non-professional phagocytizing cells in the rectal carcinoma tissue lead to an extremely unfavorable prognosis regarding overall survival. Conclusion Senescent cells can be non-professionally phagocytized and at the same time they can non-professionally phagocytize in vivo. In vitro experiments indicate that it is unlikely that senescence is a strong trigger for non-professional phagocytosis. Combined high rates of non-professional phagocytosis and high rates of senescence are an extremely poor prognostic factor for overall survival.


Introduction
Radiation therapy of cancer achieves its therapeutic effect through the induction of different types of cell death. The predominant types of cell death are apoptosis and necrosis, which are also the most widely discussed types of cell death recognized in current morphological nomenclature (1). Apoptotic and necrotic cell death as well as most other kinds of cell death mostly lead to a rapid elimination of cell remnants. In striking contrast, however, it is well known from radiotherapy that most malignancies do not resolve during multi-week fractionated radiation treatment. Indeed, most malignancies require several weeks after the end of treatment to show volumetric tumor regression in clinical and imaging assessment (2,3). In rectal cancer for example, Habr-Gama et al. found a median time interval of 18.7 weeks from completion of radiotherapy to complete endoscopic clinical response (4). An alternative route to tumor inactivation is instead of initiating cell death, to induce non-proliferative cells by triggering so-called premature senescence (5). It means that cancer cells initiate a programmed sequence of events leading to a phenotype of a stable and long-term loss of proliferative capacity, despite continued viability and metabolic activity (6). Changes observed in senescent cells include the activation of the tumor suppressor network, morphological changes, altered chromatin structure and an altered spectrum of secreted factors (7,8). Cancer therapy and especially radiochemotherapy usually causes senescence (9)(10)(11).
Senescent cells thus could be the reason for the delayed removal of cancer cells after RT. Senescent cells cause a pro-in ammatory response known as senescence-associated secretory phenotype (SASP) (12,13). This in ammation may clear the senescent cells by immune-mediated phagocytosis (14,15).
Another option to clear cells is the phagocytosis by non-professional phagocytes. It was shown that various normal tissue cells (16)(17)(18)(19) and cancer cells (20)(21)(22)(23)(24)(25) have the capability to engulf apoptotic, autophagic or necrotic cells. This leads to a cell-in-cell (CIC) phenotype and a subsequent digestion of the phagocytized cells. In cancers the frequently observed phenomenon of cell-in-cell structures by nonprofessional phagocytosis has also been referred to as "cell cannibalism" and describes the uptake and elimination of malignant cells by other cancer cells. Cell cannibalism is a very frequent nding in cancer (22,26). A so far not resolved question is whether senescent cells are cleared by non-professional phagocytes and if the increase of cell-in-cell structures and senescence in pathologic specimens are somehow related.
The aim was to study the involvement of senescence in cell-in-cell, either as a recipient cell or as an engul ng cell. We used a pancreatic carcinoma cell line and two primary broblast cell lines to act as non-professional phagocytes. It was studied whether senescent cells are preferred targets of nonprofessional phagocytosis or entotic cell death. In addition, using histologic samples from rectal cancer patients obtained prior to and after radiochemotherapy, the prevalence and prognostic signi cance of non-professional phagocytosis in rectal cancer as well as the association between tumor cell senescence and cell-in-cell structure formation were studied.

Results
Non-professional phagocytosis Dead cells induced by heat were non-professionally phagocytized by living epithelial lung cells (BEAS2B) cells. Cell death was induced by overheating to 56°C for 45 min (Figure 1 A). The living cells adhered to the dead cells and phagocytized them within two to 10 hours (Figure 1 B). Phagocytotic rates ranged from less than 0.65% to 11.5%. Normal tissue cell lines (mean value 5.6%) phagocytized more than tumor cell lines (1.2%) (p=0.001) (Figure 1 C). In the process of phagocytosis, the overheated cell was completely engulfed by the living cell (Figure 1 D, E).

Senescence in tumor and normal-tissue cell lines
The aim was to study whether senescence is a trigger for non-professional phagocytosis observed for heat-induced cell death and whether senescent cells are being phagocytized by non-senescent cells. The chemotherapeutic agent camptothecin (CPT) was used to trigger senescence in BxPC-3 cells. After six days of incubation with 120nM or 200nM CPT cells were assessed for senescence induction by detection of high-mobility group AT-hook 2 (HMGA2) protein and Histone 3 tri-methylated at the 9th lysine residue (H3K9me3) heterochromatic foci formation, ow cytometric β-galactosidase staining as well as the estimation of the nuclear size in both axes. A clear change of the staining pattern ( Figure 2A) and a distinct increase in nuclear size in both axes (Figure 2 B) was detected.
Alternatively, the induction of senescence in BxPC-3 cells was studied using immunostaining ( Figure 3A-D). After treatment with 120 nM campthothecin, the percentage of p21 staining as senescence marker increased from 19.9% to 80.1%. With 76.6% there were slightly less dead cells present compared to living cells ( Figure 3B). In the BxPC-3 cell line, the CIC rates of non-senescent cells and senescent cells were determined. 1.3% of p21+ senescent cells and 2.1% of non-senescent cells had at least one dead cell phagocyted ( Figure 3C).
Association of cell-in-cell structure formation and senescence in tumor and normal-tissue cell lines Immunostaining was used to study non-professional phagocytosis of the three cell lines. Either cells were stained green or red by uorescent live-cell stains ( Cell-in-cell structures in clinical rectal cancer tissue samples The frequency and prognostic relevance of cell-in-cell structures and senescent cells was studied in a rectal cancer cohort that was treated with neoadjuvant radiochemotherapy (RCT). A total of 96 patients with Tissue Micro Array (TMA) samples of tumor biopsy ("biopsy"), obtained during pretreatment endoscopy, were analyzed. In addition, TMA samples from the resected tumor at 6 weeks post-RCT were used for analysis. TMAs from these surgical specimens were available in 146 patients from the tumor core "central tumor", in 97 patients in the tumor invasion zone ("invasive front") and in 167 patients in surrounding normal tissue ("normal tissue"). The clinical and histological characteristics of the cohort are given in Table 1. Patients having pre-RCT biopsies, had a 5-year overall survival of 69.8%, a metastasisfree survival of 64.5% and a local recurrence-free survival of 70.1%, respectively ( Figure 5A). Post-RCT patients had a 5-year overall survival of 67.8%, a metastasis-free survival of 57.8% and a local recurrencefree survival of 61.1%, respectively ( Figure 5B). All TMAs were stained by antibodies, for anti-H3K9me3 (blue, nuclear) to detect senescent cells and for anti-E-Cadherin (red, membranous) to detect cell-in-cell structures ( Figure 5C, D).
Prevalence of senescence and cell-in-cell structures in different tumor compartments The median number of epithelial senescent cells/mm² was highest in the central tumor area (560 cells/mm 2 ) followed by normal tissue (494 cells/mm 2 ). In the biopsies and invasive front numbers of senescent cells were similar (360 cells/mm 2 vs. 369 cells/mm 2 ), respectively ( Figure 5E). The mean numbers of epithelial cell-in-cell structures/mm² were most frequent in the invasive front (1.0 cell-incell/mm 2 ) followed by the central tumor region (0.72 cell-in-cell/mm 2 ) and biopsies (0.56 cell-incell/mm 2 ). In normal tissue cell-in-cell phenomena were least common (0.08 cell-in-cell/mm 2 ) ( Figure 5F).
Prognostic signi cance of cell-in-cell and senescence rates in clinical rectal carcinoma tissue samples The prognostic relevance of senescent cells and cell-in-cell structures for the following outcomes was analyzed: overall survival, metastasis-free survival, local recurrence-free  Figure 7C, F) and both cells being senescent (18.4%, Figure   7D, F). Non-senescent cells only rarely were engulfed by senescent host cells (9.3%, Figure 7E, F). This association was highly signi cant: Senescent cells were signi cantly more frequently internalized in cellin-cell structures than constituting the external host cell (57.8% vs. 27.6%, p<0.001 Fisher's exact test).

Combination of cell-in-cell and senescence rates as prognostic factors
In addition, the prognostic relevance of combined rates of senescence and cell-in-cell phenomena was studied. The combined group having high numbers of senescent cells and high cell-in-cell/mm² rates was associated with a poor overall survival ( Figure 8A-D).
Therefore, high cell-in-cell and high senescent cell rates were compared to all others ( Figure 8E-F). Patients with high senescent and cell-in-cell rates in the central tumor had a particularly unfavorable prognosis (73.3% v. 46.9%) (p<0.001, Figure 8F). Similarly, in the normal tissue patients with "high-high" rates showed an unfavorable prognosis (71.7% v. 46.7%) (p=0.011) ( Figure 8H). Univariate and multivariate Cox's regression analyses for overall survival were performed including clinical prognosticators and TNM stage. M stage (p<0.001) and combined high cell-in-cell/mm² with high senescence/mm² in the tumor post RCT (p=0.001) were independent prognostic factors for overall survival in multivariate analysis ( Table 2).

Discussion
Cell lines with induced senescence were not phagocytized in vitro, but were able to phagocytise other cells very effectively. In contrast, naturally occurring senescent cells in rectal cancer tissue samples were phagocytized. Only 27.6% of phagocytic cells were senescent, whereas 57.8% of phagocytized cells presented a senescent state. Low cell-in-cell rates were associated with favorable overall survival. A high number of senescent cells and at the same time a high number of cell-in-cell structures in the tissue lead to an extremely unfavorable prognosis regarding overall survival.
The question whether senescent cells are a stimulus for phagocytosis has been answered contradictory. However, the results of the cellular in vitro investigations were unmistakable. In all three studied cell lines absolutely no senescent cells had been phagocytized. Since clear experimental conditions are given and a high percentage of senescent cells were available and no phagocytosis occurred at all, this strongly suggests that senescence is not a trigger for phagocytosis. In tissue, the properties of the cells are not so de nite. Even if the cells have a senescent phenotype, they may have suffered a necrotic death afterwards. In particular, radiochemotherapy involves daily radiation for about 6 weeks and additional chemotherapy. In this way cells can be driven into senescence (27) and then these cells can be damaged even further so that they die as a consequence (28). Death of senescent cells is mainly necrotic or other non programmed death (29,30). Therefore, the phagocytized cells could also be necrotically dead senescent cells. Since necrosis is a strong trigger for phagocytosis (19,31), it can lead to subsequent engulfment of the senescent cells that have died necrotically. Necrotic cells cannot actively penetrate living cells but are actively ingested by living cells. An alternative explanation could be entosis, in which one cell actively penetrates another cell and causes its own uptake in the recipient cell (32). It is thinkable that the observed cell-in-cell structures were formed by entosis and that this mechanism is applied preferentially by senescent cells. However, the experimental setup did not allow to assess this.
Another interesting issue is that heat-induced necrosis is a very strong trigger of non-professional phagocytosis. 60% of cells treated with camptothecin were identi ed as dead in the Annexin V/7AAD assay. Astonishingly, however, in contrast to the cells killed at 56°C, they were not phagocytized. This indicates that a difference exists that inhibits cells killed by camptothecin to be non-professionally phagocytized and thus prevents cell-in-cell phenomena. Additionally, this observation indicates that senescence per se is not a distinct trigger of non-professional phagocytosis.
In general cell-in-cell structures are found both in normal tissue (31) and in tumor tissue (33). A high rate of cell-in-cell structures in tumor tissue is a negative prognostic factor for example in breast carcinoma (20,34), metastasis of melanoma (24), cytology of bladder cancer (35), head and neck cancer (25,36), rectal cancer (25), oral squamous cell carcinoma (37) and lung adenocarcinoma (38). In contrast, an increased incidence of homotypic cell cannibalism in ductal adenocarcinoma of the pancreas was associated with decreased metastatic potential and consequently was a positive prognostic factor (21).
Additionally, adherent wild-type cells can act e ciently as entotic hosts, suggesting that normal epithelia may engulf and kill aberrantly dividing neighboring cells (39). High cell-in-cell rates and high senescence rates are prognostically unfavorable markers for rectal cancer patients in this study. Senescence occurred more frequently after RCT in the central tumor tissue. Cell-in-cell structures were also found more frequently in the central tumor. This study shows that high cell-in-cell rates in rectal carcinomas can be considered as an adverse prognostic marker for survival. A reason might be that the phagocytosis leads to an increased supply of substances to the tumor cells (40)(41)(42). In addition, selection of particularly malignant tumor cells is likely to occur by competition, in which the ability to engulf neighboring cells could constitute a distinct advantage (43). The poorer survival for patients with high senescence values could be explained by the senescence-associated secretory phenotype (44)(45)(46)(47). There could be an association between cell-in-cell structures and senescence. Hints for this are that senescent cell lines like broblasts and pancreas carcinoma cells phagocytize in vitro and that in vivo in 67% of cell-in-cell structures in rectal cancer TMAs senescent cells are involved. In the tissue of rectal cancer mainly senescent cells are phagocytized, but they can also phagocytize. The extremely poor survival of the subgroup with combined high senescence rates and high cell-in-cell rates is impressive. It was an independent marker for dramatically worse overall survival in rectal cancer patients. Prognostic markers are important for accurately individualizing therapies for rectal cancer patients, thereby reducing longterm costs and patient suffering (48,49). Given the strong prognostic signi cance in this investigation for rectal cancer patients, additional studies on cell-in-cell structures and senescence are clearly warranted.
We would also have liked to study non-professional phagocytosis in normal tissue. However, in these tissues the CIC rates are extremely low (31) and accordingly the events with senescence are much lower. In the tumor surrounding normal tissue of TMAs we did nd only very little CICs in this study and therefore could not investigate senescence involvement in non-professional phagocytosis. Therefore it was not possible to investigate the signi cance of senescence for CIC in normal tissue. A further limitation is that the cell experiments were only performed with heat and camptothecin treatment. In contrast, the patients were treated with radiochemotherapy. However, it was not our primary aim to perform the same treatment on cells and patients, but to induce senescence and to study senescence as a trigger for non-professional phagocytosis.

Conclusion
Senescent cells can be non-professionally phagocytized and at the same time they can nonprofessionally phagocytize in vivo. In vitro experiments indicate that it is unlikely that senescence is a strong trigger for non-professional phagocytosis. Combined high rates of non-professional phagocytosis and high rates of senescence are an extremely poor prognostic factor for overall survival.
Staining and immuno uorescence Senescence was determined either by ow cytometry or immunostaining as two independent methods. For the ow cytometric analysis, cells were incubated for 30 minutes in Ba lomycin A1 and afterwards C 12 FDG (Invitrogen, Auckland, New Zealand) was added for 60 min at 37°C. For senescence analysis by immunostaining anti-H3K9me3 (Millipore, Darmstadt, Germany), anti-HMGA2 and p21 (Cell Signaling, Leiden, Netherlands) antibodies were used. Cytoskeleton was stained by α-tubulin (Abcam, Cambridge, UK). Secondary antibodies were Alexa 488 chicken anti mouse or Alexa 594 chicken anti rabbit (Molecular Probes, Darmstadt, Germany). Phagocytosis experiments were performed using CellTrace Oregon Green (CTOG) (Invitrogen, Auckland New Zealand) for the living cells and CellTrace Far Red (CTFR) (Invitrogen, Auckland, New Zealand) for heat (56°C) for camptothecin treated cells. Cell nuclei were stained by DAPI (Roche, Grenzach-Wyhlen, Germany) and slides were mounted using Vectashield (Vector Laboratories Inc, Burlingame, USA). Cell images were acquired by a Zeiss Axio Plan 2 uorescence microscope (Zeiss, Göttingen, Germany). Nuclear size was analyzed with Biomas software (MSAB, Erlangen, Germany).

Necrosis, senescence induction and non-professional phagocytosis
Senescence was induced in cells by 120nM and 200nM camptothecin for up to 7 days. Necrosis was induced by heating cells in a hyperthermic bath at 56°C for 45 minutes. Cell death was analyzed by ow cytometry using the Annexin V-APC and 7AAD staining. The portion of β-galactosidase positive, living and necrotic cells were analyzed by ow cytometry (Gallios Flow Cytometer, Beckman Coulter, Fullerton, USA). Non-professional phagocytosis was studied by coincubating the same number of red and green cells for 4 hours. Homotypic phagocytosis experiments were always performed. The living cells and the dead cells in one experiment always came from the same cell line. For the phagocytosis trials the following cell mixtures were used: Vital green cells/heat-treated red cells, vital green cells/senescent red cells, senescent red cells/heat-treated green cells, vital green cells/vital red cells. Slides were scanned with a uorescence microscope at 400x magni cation (Carl Zeiss Microscopy, Göttingen, Germany) and Metafer4 as software (Metasystems, Altlußheim, Germany). At least 1000 vital cells were counted to calculate the cell-in-cell rates. In case of cell-in-cell rates of less than 1% a total of 3000 viable cells were counted.
Human specimens, Tissue micro arrays and immunohistochemical staining The frequency and prognostic relevance of cell-in-cell structures and senescent cells were studied in a cohort of 192 rectal cancer patients that received neoadjuvant radiochemotherapy (RCT). All samples were processed into tissue microarrays (TMAs) of 2 mm core diameter. Clinical data were obtained from the Erlangen Tumor Centre Database and from patient's records (Table 1). The average age was 64 and 63 years for pre-RCT and post-RCT specimens, respectively. The samples named "biopsies" (n=96) were collected 6 weeks prior to RCT. Concurrent chemotherapy most frequently consisted of 5-uorouracil/oxaliplatin. A post-treatment Dworak tumor regression score of grade 3 was achieved in most cases (n = 54.1%). 6 weeks after the end of neoadjuvant RCT, patients had surgical tumor resection as part of routine clinical treatment (n=146). The neoadjuvant radiochemotherapy and the time intervals correspond to the standard of treatments. Samples from the surgical specimen were taken from the "central tumor" region, the "invasive front" as well as surrounding "normal tissue". All patients signed a consent form, permitting the analysis of routinely obtained pathologic samples and clinical data for research purposes. The use of formalin-xed para n-embedded material from the Archive of the Institute of Pathology was approved by the Ethics Committee of the Friedrich-Alexander-University of Erlangen-Nuremberg on 24 January 2005. Immunohistochemical staining were performed on formaldehyde-xed para n embedded tissue microarrays. Tissue sections were dewaxed. The antigens were damasked using target removal solutions pH6 (TRS6, Dako Cytomation) in a steam cooker. Anti-E-cadherin (BD, Heidelberg, Germany) was used to visualize cell membranes by an alkalinephosphatase-labeled polymer kit (Zytochem-Plus AP-PolymerKit, Zytomed Systems, Berlin, Germany) and a fast-red color reaction (Sigma-Aldrich, Deisenhofen, Germany). Senescent cells were detected by anti-H3K9Me3 antibodies and a fast-blue color reaction (Sigma-Aldrich, Deisenhofen, Germany).
TMA Slides were scanned with a microscope at 200x magni cation (Carl Zeiss Microscopy, Göttingen, Germany) using Metafer4 software (Metasystems, Altlußheim, Germany). Intraepithelial and stromal areas of each TMA spot were identi ed by the image processing software Biomas. The senescent cells and cell-in-cell structures were manually selected. Biomas software recorded the counts in the intraepithelial area per mm². Every cell-in-cell structure was photographed and stored. Cells were regarded as senescent, when their nuclei stained positive for H3K9Me3. Cell-in-cell structures were de ned as complete enclosure of an inner cell by the membrane of an outer cell, a round nucleus of the inner cell and a semilunar enclosing by the nucleus of the outer cell.
Survival data were censored to 72 months to avoid dilution of data by untraceable drop-out of individual study participants. A corresponding cut-off was determined by a ROC curve analysis. Local failure-free survival, metastasis-free-survival, tumor-speci c survival and overall survival were determined using the Kaplan Meier method and the log rank test. Univariate and multivariate Cox regression analysis for overall survival was performed. Age, gender, TNM stage, grading, high cell-in-cell counts/mm², high senescence counts/mm² and the combination of high cell-in-cell and high senescence counts/mm² were evaluated.
Statistical analysis IBM SPSS Statistics version 21 (IBM Corp, Armonk, NY, USA) was used for statistical analysis. P-values below 0.05 were considered signi cant.

Declarations
Ethics approval and consent to participate The use of formalin-xed para n-embedded material from the Archive of the Institute of Pathology was approved by the Ethics Committee of the Friedrich-Alexander-University of Erlangen-Nuremberg on 24 January 2005.

Consent for publication
Not applicable